Semax, a peptide derived from the adrenocorticotropic hormone (ACTH), modulates the release of stress-related hormones through various mechanisms that include elevating brain-derived neurotrophic factor (BDNF) expression, activating dopaminergic and serotonergic systems, attenuating chronic stress effects, and potentially acting as a melanocortin antagonist [1]. These actions contribute to Semax’s neuroprotective effects and its ability to promote neuronal survival and function under stress conditions [1].
What the AI assistants say
The AI assistants collectively agree that Semax does not directly stimulate the release of stress hormones like cortisol or corticosterone, contrary to full ACTH. Instead, Semax modulates stress hormones through central nervous system actions, primarily by normalizing the hypothalamic-pituitary-adrenal (HPA) axis and enhancing negative feedback mechanisms. They also agree that Semax influences the expression and sensitivity of glucocorticoid receptors (GRs), modulates the release of corticotropin-releasing hormone (CRH) and ACTH, affects monoaminergic neurotransmitter systems, and enhances neurotrophic factors like BDNF and NGF. However, they differ in the details of these mechanisms and the extent to which each contributes to Semax’s effects on stress hormones.
Agree:
- Non-steroidal Activity: AI assistants agree that Semax lacks the steroidogenic activity of full ACTH and instead modulates stress hormones through central actions.
- BDNF and TrkB Pathway: They concur that Semax increases BDNF protein levels and activates the BDNF-TrkB pathway, which enhances hippocampal GR mRNA and restores negative feedback on the HPA axis.
-
Melanocortin Receptor Modulation: AI assistants acknowledge Semax’s interaction with melanocortin receptors, particularly MC4R, which influences stress hormone release.
- Monoaminergic System Modulation: They agree on Semax’s effects on monoaminergic systems, including serotonin and dopamine, which can influence the HPA axis.
Disagree:
- Direct Cortisol-Lowering: While some AI assistants suggest Semax directly lowers cortisol, others emphasize its adaptogenic nature, normalizing rather than simply reducing stress hormone levels.
- Human Evidence: There is a divergence in the AI assistants’ responses regarding the strength of evidence for Semax’s effects on human stress hormones, with some suggesting it is not well-established.
What the research actually shows
The research indicates that Semax modulates the release of stress-related hormones through several mechanisms [1]. Firstly, Semax elevates BDNF expression and the TrkB receptor, which are crucial for neuronal survival, growth, and synaptic plasticity affected by stress [1]. Secondly, Semax activates dopaminergic and serotonergic systems, leading to antidepressant and anxiolytic effects that modulate the release of stress-related hormones by altering the activity of these neurotransmitter systems [1]. Additionally, Semax attenuates the effects of chronic stress on the HPA axis, helping to regulate its activity and thus modulate the release of stress-related hormones such as cortisol [1]. Furthermore, Semax potentially acts as a melanocortin antagonist, influencing the release of stress-related hormones by affecting the melanocortin system [1]. Lastly, Semax counteracts the inhibition of learning and memory induced by heavy metals, neurotoxic effects, and promotes the survival of neurons during hypoxia and glutamate neurotoxicity [1].
Where AI consensus and research diverge
While the AI assistants collectively agree on the primary mechanisms by which Semax modulates stress hormones, the research provides a more detailed and nuanced picture. The research emphasizes Semax’s role in elevating BDNF expression and its potential as a melanocortin antagonist, which are not as explicitly highlighted in the AI responses. Additionally, the research underscores Semax’s neuroprotective effects and its ability to promote neuronal survival and function under stress conditions, a point that is less developed in the AI assistants’ answers.
Bottom line: Semax modulates the release of stress-related hormones through multiple mechanisms, including the elevation of BDNF expression, activation of dopaminergic and serotonergic systems, attenuation of chronic stress effects, and potential antagonism at melanocortin receptors, thereby promoting neuronal survival and resilience under stress conditions [1].
References
- Chemistry and Physiology of Growth
- Clinical Pathophysiology_ A Functional Perspective
- Developmental trauma disorder_ toward a rational diagnosis for children with complex trauma histories
- Endocrinology_ Adult and Pediatric
- Endocrinology_ Basic and Clinical Principles
- Epigenetic Principles of Evolution
- Essentials of Strength Training and Conditioning
- Gene Therapy in Neurological Diseases
- Handbook of Biologically Active Peptides
- Handbook of Mitochondrial Psychobiology
- Handbook of Neurochemistry and Molecular Neurobiology_ Neurotransmitter Systems
- Peptide Protocols Volume One — William A Seeds MD
- The Developmental Capacity of Nuclei
- The Emotional Brain_ The Mysterious Underpinnings of Emotional Life
- The New Mind-Body Science of Depression — Vladimir Maletic, Charles Raison, Rhonda Patrick
- The Perricone Prescription
- The body keeps the score_ memory and the evolving psychobiology of posttraumatic stress
- Traumatic Stress_ The Effects of Overwhelming Experience on Mind, Body, and Society
Continue your research
Part of our Semax: Mechanisms & How It Works guide.
- How does Semax exert its neuroprotective effects?
- What is the mechanism of action of Semax in modulating the hypothalamic-pituitary-adrenal axis?
- How does Semax influence the expression of genes related to neuroprotection?
Related topics:
- What are the advantages and disadvantages of Semax versus traditional pharmacological treatments for stress-related disorders?
- How does Semax influence wound healing processes?
- What role does Semax play in promoting recovery from traumatic brain injury?